Invesaro

Stocks Health care AMRN

NASDAQ · Health care

Amarin Corp PLC (AMRN)

Amarin Corp PLC brought in $186.2M of revenue over the twelve months to June 30, 2026, down 15.1% from a year earlier. It posted a net loss of $27.1M. At June 30, 2026 it held $143.6M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on July 29, 2026.

Revenue (last 12 months)
$186.2M
-15.1% year on year
Net margin
-14.6%

What Amarin Corp PLC does

Amarin Corp PLC is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker AMRN.

Revenue and profit by year

Revenue
FY18: $229.2M $229.2M FY18FY19: $429.8M $429.8M FY19FY20: $614.1M $614.1M FY20FY21: $583.2M $583.2M FY21FY22: $369.2M $369.2M FY22FY23: $306.9M $306.9M FY23FY24: $228.6M $228.6M FY24FY25: $213.6M $213.6M FY25
Net income
FY18: -$116.4M -$116.4M FY18FY19: -$22.6M -$22.6M FY19FY20: -$18M -$18M FY20FY21: $7.7M $7.7M FY21FY22: -$105.8M -$105.8M FY22FY23: -$59.1M -$59.1M FY23FY24: -$82.2M -$82.2M FY24FY25: -$38.8M -$38.8M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$213.6M-$50.2M-$38.8M-$0.09n/a
2024$228.6M-$91.8M-$82.2M-$0.20n/a
2023$306.9M-$67.6M-$59.1M-$0.15n/a
2022$369.2M-$105.9M-$105.8M-$0.26n/a
2021$583.2M$10.5M$7.7M$0.02n/a
2020$614.1M-$19.7M-$18M-$0.05-$22M

Latest SEC filings

What Amarin Corp PLC has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 27, 2026
    Activist stake changed SCHEDULE 13D/A
  2. July 29, 2026
    Quarterly report 10-Q · period to June 30, 2026
  3. July 29, 2026
    Quarterly results 8-K
  4. May 15, 2026
    Shareholder vote results 8-K
  5. April 29, 2026
    Quarterly report 10-Q · period to March 31, 2026
  6. April 29, 2026
    Quarterly results 8-K
  7. April 10, 2026
    Annual report to shareholders ARS
  8. April 10, 2026
    Proxy statement DEF 14A
  9. March 30, 2026
    Preliminary proxy statement PRE 14A
  10. March 27, 2026
    Executive or director change 8-K

Recent insider filings (Forms 3, 4 and 144): 10, the latest on August 3, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about AMRN

What does Amarin Corp PLC do?

Amarin Corp PLC is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker AMRN.

Is Amarin Corp PLC profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $27.1M on revenue of $186.2M.

How much revenue does Amarin Corp PLC make?

Over the twelve months to June 30, 2026 Amarin Corp PLC reported revenue of $186.2M. That is 15.1% less than a year earlier.

When did Amarin Corp PLC last report?

Its most recent periodic report is the quarterly report (10-Q) filed on July 29, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the activist stake changed from August 27, 2026.

Similar companies

JNJ
Johnson & Johnson
LLY
ELI LILLY & Co
MRK
Merck & Co., Inc.
PFE
Pfizer Inc
ABBV
AbbVie Inc.
AZN
Astrazeneca PLC

Follow AMRN

Get an email when Amarin Corp PLC files with the SEC: results, executive changes, material agreements and annual reports.

Follow AMRN: get an email when it files

Where the numbers come from

Financial figures are the values Amarin Corp PLC tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.